Alan Palkowitz (2019)

Alan PalkowitzAlan Palkowitz, Ph.D., is currently senior research professor of medicine in the Department of Clinical Pharmacology at the Indiana University (IU) School of Medicine. He is a key contributor to multiple translational programs focusing on Alzheimer’s disease and pediatric cancers as part of the IU Precision Health Initiative. Palkowitz most recently was the vice president of discovery chemistry research and technologies at Eli Lilly and Company, where he worked for 28 years. In his role as vice president, Palkowitz was responsible for the global small-molecule strategy and delivery of clinical candidates in all areas of disease focus, including cancer, diabetes, immunology, pain and neurodegenerative disorders. Palkowitz oversaw a large, multisite global research enterprise that included medicinal chemistry, computational and biophysical/structural sciences, molecular and cellular pharmacology, analytical technologies, synthetic technologies, and automation sciences. Palkowitz championed the creation of multiple molecular discovery strategies to diversify approaches to drug discovery and successfully expand therapeutic innovation. In addition, he designed and implemented unique business models aimed at expanding global access to diverse talent and capabilities in partnership with academic centers, small biotech companies and government researchers. As a member of the Lilly Research Laboratories leadership team, Palkowitz participated in setting strategic direction for the company, along with technical governance of the discovery and early clinical development pipeline. He currently serves on several advisory groups, including the NCATS Advisory Council and the National Academy of Sciences Board on Chemical Sciences and Technologies.